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Summary: A key challenge in clinical proteomics of cancer is the identiﬁ  cation of biomarkers that could allow detection, 
diagnosis and prognosis of the diseases. Recent advances in mass spectrometry and proteomic instrumentations offer unique 
chance to rapidly identify these markers. These advances pose considerable challenges, similar to those created by 
microarray-based investigation, for the discovery of pattern of markers from high-dimensional data, speciﬁ  c to each patho-
logic state (e.g. normal vs cancer). We propose a three-step strategy to select important markers from high-dimensional 
mass spectrometry data using surface enhanced laser desorption/ionization (SELDI) technology. The ﬁ  rst two steps are the 
selection of the most discriminating biomarkers with a construction of different classiﬁ  ers. Finally, we compare and validate 
their performance and robustness using different supervised classiﬁ  cation methods such as Support Vector Machine, Linear 
Discriminant Analysis, Quadratic Discriminant Analysis, Neural Networks, Classiﬁ  cation Trees and Boosting Trees. We 
show that the proposed method is suitable for analysing high-throughput proteomics data and that the combination of logistic 
regression and Linear Discriminant Analysis outperform other methods tested. 
Keywords: mass spectrometry, Wilcoxon’s test, logistic regression, supervised classiﬁ  cations
Introduction
Over recent years, scientiﬁ  c knowledge in cancer biology has progressed considerably. However, the 
practical impact of this research on screening, diagnosis, prognosis and monitoring remains limited. 
New methods must be developed to identify the physiological and pathological mechanisms in the 
origin and spread of tumors. Such approaches are essential for the discovery, identiﬁ  cation and valida-
tion of new bio-markers. Recently, progress in mass spectrometry system, such as surface enhanced 
laser desorption/ionization time-of-ﬂ  ight (SELDI-TOF), has opened up interesting perspectives for 
identifying these markers or establishing speciﬁ  c protein proﬁ  les that may be used for cancer diagnosis 
(Adam, 2002; Petricoin, 2002; Zhang, 2004; Solassol, 2006). In this work, we considered SELDI raw 
data in attempt to discriminate cancer from benign diseases. After protein ionization and desorption 
with a laser, the mass spectrum is represented by the intensity of the proteins ﬁ  xed on the chip 
(y-coordinate) as a function of the mass-to-charge (m/z) ratio (x-coordinate). From the spectra, the 
initial pre-processing steps are (a) the normalization and calibration to limit any bias caused by the 
instruments or the operator, (b) baseline subtraction, (c) peak detection, and (d) peak alignment to allow 
the same x-coordinate in all the spectra. One of the best challenges and the most important steps is then 
to reduce the high- dimension of these spectra to extract the discriminatory features or the best combi-
nation of markers capable of differentiating between two classes of interest (Duda, 2001). For this last 
step, spectra are processed using computerized algorithms based on multivariate statistical analyses. 
Several different mathematical algorithms have been applied to elucidate statistically signiﬁ  cant differ-
ences such as cluster analysis, genetic algorithms, discriminate analysis, neural networks or hierarchical 
classiﬁ  cation (Bauer, 1999; Petricoin, 2002; Vlahou, 2003; Wu, 2003). 296
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In this work, we developed a three-step 
strategy to extract markers or combination of 
markers from high-dimensional SELDI data. 
From the pre-processing step, we detected 228 
peaks, but among them some were not charac-
teristic of the disease and were identically 
expressed in the two considered groups (cancer 
and benign disease). To allow an optimal iden-
tification of differentially expressed peaks, a 
preselection strategy of discriminating biomar-
kers combinations was chosen, rather than a 
simple filtering of the data by only a two-sided 
statistical test which was not taking into account 
the biomarkers inter-correlation. Next, we 
focused on different supervised classification 
methods due to the consideration that an a priori 
information coming from the training sample 
can allow the identification of the optimal diag-
nostic combinations. We compared the perform-
ance and the robustness of these various super-
vised classification methods and discussed their 
respective strengths and weaknesses.
Data Set and Pre-Processing
The study involved a total of 170 serum samples 
collected at the Arnaud de Villeneuve University 
Hospital (Montpellier, France) with institutional 
approval: 147 patients with pathologically 
conﬁ  rmed cancer and 23 patients suffering from a 
benign disease in the related organ. Whole blood 
was collected during fasting and all samples were 
processed within 1 h of collection and rapidly 
frozen at –80 °C before analysis. An anion-
exchange fractionation procedure was performed 
before surface-enhanced laser desorption/ionisa-
tion time-of-ﬂ  ight mass spectrometry analysis. 
Serum samples were thus separated into six 
different pH gradient elution fractions, referred as 
to F1, F2, F3, F4, F5 and F6. Each fraction was 
randomly applied to a weak cation exchange 
ProteinChip array surface (CM10) in a 96-well 
format. F2 was not subjected to analysis due to the 
weak number of peaks detected in preliminary 
experiments. Arrays were read on a Protein Biolog-
ical System II ProteinChip reader (Ciphergen 
Biosystem). Peak detection was performed using 
the ProteinChip Biomarker software (version 3.2.0, 
Ciphergen Biosystem Inc.). Spectra were back-
ground subtracted and the peak intensities were 
normalized to the total ion current of m/z between 
2.5 and 50 kDa. Automatic peak detection was 
performed in the range of 2.5 to 50 kDa with the 
following settings: i) signal-to-noise ratio at 4 for 
the ﬁ  rst pass and 2 for the second pass, ii) minimal 
peak threshold at 15% of all spectra, iii) cluster 
mass window at 0.5% of mass. The resulting CSV 
ﬁ  le containing absolute intensity and m/z ratio was 
exported into Microsoft Excel (Microsoft, 
Redmont) for subsequent analysis.
Biomarkers Selection
Initially, a selection of the most discriminating 
biomarkers was carried out. The 228 peaks detected 
by Ciphergen software are aligned. A peak is 
deﬁ  ned as discriminating when the intensities of 
the individuals of the cancer group are signiﬁ  cantly 
different than the reference group. Initially the 
peaks differentially expressed in the two groups 
were selected using the two-sided Wilcoxon’s test. 
After this preselection, a combination of discrim-
inating peaks is required by using a logistic regres-
sion (Pepe, 2006). 
Wilcoxon’s test
The assumption that each peak intensity follows a 
normal distribution has been rejected using a 
Shapiro-Wilk normality test in each group. A two-
sided Wilcoxon’s test was employed to test the  H0 
assumption of equality of the intensities in the two 
groups. We correct the loss of power induced by 
multiple tests by the false discovery rate (FDR) 
approach (Verhoeven, 2005; Benjamini, 1995). 
FDR is the expected proportion of type I errors 
among all signiﬁ  cant results (V/r), where V is the 
number of type I errors (‘‘false discoveries”), and 
r is the number of signiﬁ  cant tests. A procedure to 
control FDR at level α was proposed by Benjamini 
and Hochberg (1995). That consists initially of 
ranking by ascending order the 228 p-values that 
we note now by : p(1)  p(2)  …  p(228), and H(i) 
denote the null hypothesis corresponding to p(i). 
The second stage consists of the search for k which 
is largest i for which:
  pi i () . 
α
228  
This resulting p-value p(k) is the threshold p-value 
for each test taken individually, such as we reject 
all the null assumptions H(1) , …, H(k) (Fig. 1). The 
null assumption has been rejected for k = 100 
biomarkers.297
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Binary logistic regression
The Wilcoxon’s retains the most discriminating 
peaks. On the other hand, the logistic regression 
combines several biomarkers to ﬁ  nd the best model 
allowing classiﬁ  cation in cancer/control groups. 
Let us consider the diagnosis variable Y to be 
modelled, which takes two values:
•  Y = 1 for all the individuals that  belong to the 
cancer group.
•  Y = 0 for all the individuals that belong to the 
control group. 
The outputs to be modelled Yi|xi follows a 
Bernouilli distribution of parameter πi = P(Yi = 
1|xi), where xi is a vector line of the actual values 
for the explanatory variables. The logit of the 
multiple logistic regression (Hosmer, 2000) is 
given by 
 f (x) = logit (P(Y = 1|x)) = β0 + β1x1 + ... + βp xp . 
where (x1,…, xp) is a collection of p biomarkers 
selected in the model.
The classical model-building strategy is to ﬁ  nd 
the most parsimonious model that explains the 
data. This provides a general and numerically 
stable model. To study the robustness of the logistic 
regression predictor’s selection, the two strategies 
of models-building forward and stepwise were 
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Figure 1. Application of Benjamini and Hochberg FDR control on the 228 Wilcoxon’s test p-values ranked by ascending order.298
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square for entering an effect into the model was ﬁ  xed 
at 0.05 in the forward and stepwise logistic regres-
sions. A signiﬁ  cance level of 0.05 is considered in 
the Wald chi-square test to test if an effect must 
stay in the stepwise logistic regression which was 
implemented with SAS software (version 8.1). A 
weight of 1 and 147/23 was affected to the cancer 
and control groups, respectively. This weighting 
was employed because the control sample is 
subsampled. 
The estimated logit in the forward selection is 
given by the following expression:
 


























The estimated logit in the stepwise selection is 
given by the following expression:
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where Pj
Fk designed the jth peak in the original 
biomarkers matrix which contains 228 peaks and 
Fk indicates that this peak was detected in the kth 
fraction. The AUC for the two models were 0.988 
for the forward strategy and 0.995 for the stepwise 
strategy. The forward and stepwise logistic regres-
sion modelled the logit with 6 and 8 biomarkers 
ranging from 3 to 48 kDa. The most stable peaks 
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peaks is estimated by:
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for an AUC of 0.973.
These three models produced  above were used 
in the comparison  of the supervised classiﬁ  cation 
techniques. For the moment, the AUC is the only 
criterion which makes it possible to evaluate the 
model in term of classiﬁ  cation. 
Overview of the Supervised 
Classiﬁ  cations Used
Supervised classiﬁ  cation techniques consist in a 
deﬁ  nition of a classiﬁ  cation rule based on a training 
set for which the true class-label is known. The 
matrix x denotes the biomarkers matrix with 
n = 169 lines (i.e. individuals) and p columns, 
where p is the number of biomarkers retained in 
the different logistic regressions. Also, x1,…, xp 
denote the p biomarkers contained in the columns 









p and the N 
class-labels corresponding y
(i) ∈{−1,1}. In the 
training set, the true class-label y
(i) adopted in 
the next sections are the following:
y
(i) = –1, if the sample point x
(i) belongs to the
 cancer  group,
y
(i) = 1, if the sample point x
(i) belongs to the
 control  group.
where, the ith line of the matrix x
(i) represents 
the p coordinates of the ith training sample 
point.
Support vector machine
A Support Vector Machine (SVM) is a supervised 
learning technique that constructs an optimal 
separating hyperplane from the training set with 
an aim of classifying the test set (Vapnik, 1998; 
Hastie, 2001; Lee, 2004; Li, 2004). When the data 
are not linearly separable, one solution for the 
classiﬁ  cation problem is to map the data into the 
feature space that is usually a higher-dimensional 
space using a function φ usually non linear. Thus, 
for x
(i) the ith vector in the original input space   
φ(x
(i)) is the corresponding vector in the feature 
space. The value of the kernel function K on (x
(i), 
x
(j)) computes the inner product of φ(x
(i)) and φ(x
(j)) 
in the feature space. The radial basis kernel is 








where c > 0 is a scalar. 
The search of the discriminant function  f (x) = 
φ(x)
T β + β0 is formulated into the following opti-
mization problem
  min
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subject to ξφ β β ξ i
ii T
i yx i  01 0 ,( ) ,
() () + () −∀ ,
where γ > 0 is a constant and ξi are the slack vari-
ables. This optimization problem is solved by 
maximizing the Lagrangian dual objective function. 
The solution ˆ β for β has the form of linear combi-
nation of the terms  yx
ii () () () φ  and ˆ β 0 is the common 
value that solve  yx
ii T () () [( )ˆˆ ] φβ β += 0 1  for each i. 
The decision function can be written as
 







⎦ φβ β 0  
In other words, if Ĝ(x
(j)) = −1 then j th observation  
x
(j) of the sample test has a class-label y
(j) equal to 
–1 and will belong to the cancer group, else the 
class-label is equal to 1 and the individual x 
(j) will 
belong to the control group.
Linear discriminant analysis 
and quadratic discriminant analysis
Suppose that fk (x) is the density of the observations 
x in the k th class, and πk denote the prior proba-
bility of class k, where  πk k= ∑ = 1
2 1. The Bayes 
theorem gives us













2 and k ∈{} 12 , . 
The classiﬁ  cation rule for the test set is to affect 
the observation x' at the k th class with maximal   
probability  PY kX x () == ' . For linear and 
quadratic discriminant analysis, the densities fk are 
modelled as p-multivariate Gaussian (Webb, 2002; 
Lee, 2004). To compare the two classes k and l, the 































•  Quadratic discriminant analysis (QDA) is the 
general discriminant problem, where  the deci-
sion boundary  xx x kl :( ) ( ) δδ = {}  between the 
two classes is a quadratic equation in x. The 
quadratic discriminant function is deﬁ  ned as
















•  Linear discriminant analysis (LDA) arises when 
the covariance matrix Σk and Σl  are assume 
equals ΣΣ k k =∀ , . Then, the decision bound-
ary between classes k and l is an equation linear 
in x in a p-dimensions hyperplane.
In practice, the true parameters of the Gaussian 
distributions are not known, but we can estimate 
them using the training set. Also, an estimate ˆ δk of 
δk can be obtained and the decision rule can be 
written as
  ˆ( ) argmax ˆ () . Gx x
k
k =δ  
Single-layer neural network
Artiﬁ  cial neural networks (ANN) are learning 
algorithms that are modelled on the neural activity 
of the brain (Hastie, 2001; Dreyfus, 2002; Chen, 
2004; Lee, 2004). Each node represents a neuron, 
and the connections represent the synapses (Fig. 2). 
A constant entry x0 = 1N is included in the whole 
perceptron entries, affected of a weight w0. The 
constant w0 is often referred as the bias and –w0 is 
called the threshold. Also, x = (x0, x1, x2, …,  xp) 
denote the input variables such as xj ∈ℜ
N; w = (w0, 
w1, w2, …, wp) denote the associated weight vector. 
The training set is used to ﬁ  nd the appropriate 
values of the synaptic weights vector (w0, w1, w2, 
…, wp) in neural networks to solve the classiﬁ  ca-
tion problem. If the two classes are linearly sepa-
rable, it exists a decision boundary {x: w
T x = 0}. 
If w
T x > 0, is in the ﬁ  rst class and if w
Tx > 0, x is 
in the second class. A decision rule Ĝ(x) can be 
deﬁ  ned in terms of a linear function of the input x 
as follows
  Ĝ(x) = sign (w
T x),  
where sign(z) denotes the sign of the quantity z. 
Let the risk function R(w) measures the success of 
a decision rule by comparing the true labels y
(i) 
with the predicted labels Ĝ(x
(i)). The weight vector  
w is chosen to minimize the risk function. A current 
choice for the risk function is the sum of squared 
errors. The gradient descent procedure can be used 
to ﬁ  nd optimum weights ŵ in term of risk, and the 
decision rule can be written as
  Ĝ(x) = sign (w
T x). 300
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Classiﬁ  cation trees
A classification tree is a multi-stage decision 
process that divides successively the whole of the 
N training sample observations in two homoge-
neous segments with regard to the class-labels by 
using the p biomarkers x1, …,  xp (Hastie, 2001;Yang, 
2005). The algorithm needs to select automatically 
a splitting rule for each internal node. This means 
determining a splitting variable xj jp l l∈{} 12 ,, , …  with 
an associated threshold Sl that has been used to 
partition the data set at each node in two regions : 
RL(jl, sl) = {x|xjl  ≤ sl} and RR(jl, sl) = {x|xjl > sl}. For 
each splitting variable xjl, the threshold sl is deter-





,, , =12… , and the determination of the best pair 
(jl, sl) in term of maximization of the decrease in 
the node impurity function. In this article, the 
decrease in the node impurity function is expressed 
according to the Gini criterion. The splitting 
process is repeated on each of the two resulting 
regions of the previous step, and this until the stop-
ping rule stops the process. The splitting process 
(Nakache, 2003) is stopped when the segment is 
pure (it contains subjects of the same class), if it 
contains identical observations, or if it contains a 
small number of subjects. Then this large tree is 
pruned using cost-complexity pruning. The ﬁ  nal 
tree retained is noted by Tâ (Fig. 3). For the K class 
(here K = 2) and the M nodes in the ﬁ  nal tree Tâ , 
the proportion of class k observations in terminal 
node m was computed as

















where Nmis the size of the training sample in 
the region Rm. For xR m ∈  the decision rule is to 
affect x in the majority class in node m, and it can 
be written as
  ˆ ( ) argmax ˆ Gx p m
k
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Figure 2. Schematic of a single-layer neural network.301
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In other words, in the particular case where K = 2 
for each ﬁ  nal node m of the ﬁ  nal tree the assign-
ment rule can be also written in the following 
term:
If  ˆ . pmk 05  then the individuals of the node m 
are assigned  to the class k, else they are assigned 
to the remaining class.
Boosting trees
The purpose of boosting is to apply M times the 
weak classification algorithm on the weighted 
training data, so as to produce a sequence of 
weak classifiers Gm(x), m = 1,2, …, M (Hastie, 
2001; Fushiki, 2006). Then, a strong classifier 
is built by making a linear combination of the 
weighted sequence of weak classifiers. For a 
vector variables X, a classifier Gm(X) produces 
a prediction of the class-label Y that  belongs 






























i () is the weight associated to the i th 
observation of the training sample at the mth 
step. A weak classifier is one whose error rate 
is only slightly better than random guessing. 
The weights are initialized with wN
i
iN 1 12 1
()
;, , /. = = …  
For each iteration m = 2,3,…, M the observation 
weights are modified and the classification 
algorithm is reapplied to the weighted observa-
tions. The error rate εm is computed and the 
weights of the observations at the m+1th step 
are recomputed as 












() () () () .exp . ( ) ,   
  i = 1,2, …,  N 





N1 , p11, p12 N2 , p21, p22 N3 , p31, p32







xj1 ≤ S1 xj1 > S1
xj2 > S2 xj3 ≤ S3 xj3 > S3
xj4 ≤ S4 xj4 > S4
∈Rm
Gm ( ) = arg max pmk
is:
The decision rule for
( j2, S2)
RL ( j1, S1 ) RR( j1 , S1)
R2 = RR( j2, S2) R3 = RL( j3, S3)
R4 = RL( j4 , S4) R5 = RR( j4 , S4)
RR( j3,S3)
ˆ ˆ ˆ ˆ ˆˆ
ˆˆ ˆˆ ˆˆ






Figure 3. Schematic of an example of classiﬁ  cation tree with 5 terminal nodes.302
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where αm = log((1–εm)/εm). In other words, at the 
step m the observations misclassified at the 
previous step have their weights increased 
(Nakache, 2003), and on the contrary the weights 
of the well classiﬁ  ed observations are decreased. 
The predictions from all of them are then combined 
trough a weighted majority vote to produce the 
ﬁ  nal prediction:












The cross-validation is applied on biomarker selec-
tions combined with different classiﬁ  cation methods. 
The logistic regression, which took part at the prese-
lection step, was also used as a discriminant analysis 
method in the cross-validation. The aim of this step 
is to validate our method of marker selections, while 
comparing the predictive power of the different 
supervised classiﬁ  cation methods with this selection 
method. We applied the holdout method for the 
cross-validation. That consists on repeating the 
algorithm of decision rules construction described 
below, and to estimate their performances. First, the 
cross-validation consists on a random drawing of a 
training sample. The training sample size N was 
varied from 40%, 60%, and 80% of the total sample 
size n = 169. The remaining sample is named test 
sample. The features number of the training sample 
is limited to these p most discriminating features 
described above, such as x ∈ℜN×p. The decision rule 
G(x) is evaluated using the training set whose class-
labels are known, and that for the different super-
vised classiﬁ  cation techniques studied in this article. 
The class-label of each test sample observation is 
predicted using the decision rules G(x). The class-
labels of the test sample being known, the predic-
tions of the different methods can be evaluated by 
the calculation of TP, TN, FP, FN, where TP, TN, 
FP, FN means the number of true positive, true 
negative, false positive and false negative samples, 
respectively. These numbers are computed in each 
test set of the 1000 iterations of the cross-validation 
and summed. For each classiﬁ  cation method, the 
sensitivity, the speciﬁ  city and the accuracy was 
calculated to compare them. The sensitivity is 
deﬁ  ned as TP/(TP+FN) which represents the ability 
of a classiﬁ  cation method to classify correctly the 
patients reached of cancer, and the specificity 
deﬁ  ned as TN/(TN+FP) the percentage of observa-
tion of the control sample correctly classiﬁ  ed. The 
accuracy is deﬁ  ned as (TP+TN)/(TP+TN+FP+FN) 
and measures the percentage of whole of observa-
tions correctly classiﬁ  ed. The cross-validation was 
applied to the three biomarkers selections using, 
under the R software, the package CaMassClass 
(www.r-project.org) dedicated to the treatment of 
Protein Mass Spectra (SELDI) Data.
Results and Discussion
The goal of our article was to detect biomarkers 
and to assess their discriminating capacity using 
the different several supervised classification 
methods. In this way, we believe that cross-validation 
can answer to this question. We developed a three-
step strategy to extract markers or combination of 
markers and to evaluate the robustness of these 
classiﬁ  ers. First, protein peaks from 228 protein 
clusters were selected by a Wilcoxon test. Then, 
logistic regression models were used to construct 
two discriminating subsets of features composed 
of 6 and 8 protein peaks, ranging from 3 to 48 kDa, 
using forward (Table 1) and stepwise (Table 2) 
logistic regressions respectively. A third subset of 
discriminating markers (Table 3) was built by 
taking the intersection of the two ﬁ  rst. Since there 
was no gold standard method for classiﬁ  cation of 
mass spectrometry data, we were interested in 
comparing the performance and the robustness of 
different classiﬁ  cation approaches. The unsuper-
vised and supervised classiﬁ  cation methods have 
been evaluated, but only the latter that showed the 
most satisfying results was presented in this 
paper.
The mean performance (accuracy, sensibility 
and speciﬁ  city) of our classiﬁ  ers on 1000 randomly 
generated 80:20, 60:40 and 40:60 set of samples 
were evaluated using different class-prediction 
models. The results showed that the forward 
logistic regression is better than the stepwise 
logistic regression in terms of accuracy and 
speciﬁ  city. Interestingly, 5 protein peaks were 
common to the two models. A classiﬁ  er with the 
protein peaks common to these two model selection 
methods allowed a more parsimonious model, as 
effective as the forward logistic regression 
(Table 3).  Then it can be pointed out that the 
speciﬁ  city was lower than the sensitivity and did 
not exceed the 0.86. The least effective supervised 
classiﬁ  cation methods was the classiﬁ  cation trees 303
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Table 1. Cross-validation forward.
 Training    TP  TN  FP  FN  Sensitivity  Speciﬁ  city  Accuracy
 sample 
 size  (%)
Binary logistic   0.4  82371  11148  2852  5629  0.9360  0.7963  0.9169
regression 0.6  53525  7547  1453  4475  0.9228 0.8386 0.9115
 0.8  26657  4289  711  2343  0.9192  0.8578  0.9102
SVM 0.4  83580  9666  4334  4420  0.9498  0.6904  0.9142
 0.6  55035  6761  2239  2965  0.9489  0.7512  0.9223
 0.8  27677  3868  1132  1323  0.9544  0.7736  0.9278
LDA 0.4  82465  11603  2397  5535  0.9371  0.8288  0.9222
 0.6  54676  7510  1490  3324  0.9427  0.8344  0.9281
 0.8  27483  4159  841  1517  0.9477  0.8318  0.9306
QDA 0.4  82687  6647  7353  5313  0.9396  0.4748  0.8758
 0.6  52177  6695  2305  5823  0.8996  0.7439  0.8787
 0.8  25860  4064  936  3140  0.8917  0.8128  0.8801
Neural  0.4  86408  10132  4830  1592  0.9819  0.6772  0.9376
Networks 0.6  56932  6819  2181  1068  0.9816  0.7577  0.9515
 0.8  28535  3828  1172  465  0.9840  0.7656  0.9519
Classiﬁ  cation   0.4  80945  3508  10492  7055  0.9198  0.2506  0.8280
Trees 0.6  53202  2554  6446  4798  0.9173  0.2838  0.8322
 0.8  26804  1354  3646  2196  0.9243  0.2708  0.8282
Boosting  0.4  84585  4921  9153  3415  0.9612  0.3497  0.8769
Trees 0.6  55461  3278  5918  2539  0.9562  0.3565  0.8741
 0.8  27708  1668  4580  1292  0.9554  0.2670  0.8334
Table 2. Cross-validation stepwise.
  Training    TP TN FP FN  Sensitivity  Speciﬁ  city  Accuracy
  sample                
  size  (%)            
Binary logistic 0.4  78024 9594  4406  9976 0.8866  0.6853  0.8590
regression 0.6  50115  6878  2122  7885  0.8641 0.7642  0.8506
 0.8  24871  3942  1058  4129  0.8576  0.7884  0.8474
SVM 0.4  81876  7211  6789  6124  0.9304  0.5151  0.8734
 0.6  53604  5122  3878  4396  0.9242  0.5691  0.8765
 0.8  26802  2941  2059  2198  0.9242  0.5882  0.8748
LDA 0.4  79379  10253  3747  8621  0.9020  0.7324  0.8787
 0.6  52929  6682  2318  5071  0.9126  0.7424  0.8897
 0.8  26691  3614  1386  2309  0.9204  0.7228  0.8913
QDA  0.4  83320 3909  10091 4680 0.9468  0.2792  0.8552
 0.6  52004  5052  3948  5996  0.8966  0.5613  0.8516
 0.8  25690  3219  1781  3310  0.8859  0.6438  0.8503
Neural   0.4  85758  7750  6694  2242  0.9745  0.5366  0.9128
Networks 0.6  56802  5317  3683  1198  0.9793  0.5908  0.9271
 0.8  28527  2891  2541  473  0.9837  0.5322  0.9125
Classiﬁ  cation   0.4  81399 3459  10541 6601 0.9250  0.2471  0.8319
Trees 0.6  53351  2592  6408  4649  0.9198  0.2880  0.8350
 0.8  26680  1388  3612  2320  0.9200  0.2776  0.8255
Boosting   0.4  80072  3654  7799  1401  0.9828  0.3190  0.9010
Trees 0.6  52540  2480  5605  849  0.9841  0.3067  0.8950
 0.8  26102  1408  5322  455  0.9829  0.2092  0.8264304
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and the boosting trees that failed to correctly 
classify individuals of the control group. Although 
the sensitivity of both methods was acceptable, it 
was not the case for the speciﬁ  city that was found 
lower than 0.36. Comparing to Quadratic Discrim-
inant Analysis, the Linear Discriminant Analysis 
gave the best performance result to discriminate 
both samples achieving a mean classification 
accuracy of 0.93, a sensitivity of 0.95, and a 
speciﬁ  city of 0.83 with a 80:20 cross-validation 
set samples (Table 1). The Linear Discriminant 
Analysis was slightly better than the Logistic 
Regression in terms of accuracy, and sensitivity. 
The results from SVM and Neural Networks were 
similar in terms of mean performance but showed 
a lower mean specificity (0.78) compared to 
Discriminant Analysis and Logistic Regression 
methods (0.86). Finally, the model selection robust-
ness was conﬁ  rmed by using different training 
sample sizes that varied from 40 to 80%. Interest-
ingly, all the selection methods were stable with 
all the training sample size tested, except for 
Quadratic Discriminant Analysis. The Linear 
Discriminant Analysis remained the most robust 
method with a mean speciﬁ  city ranging from 0.82 
to 0.83, and sensitivity from 0.93 to 0.95 with the 
different sample sizes tested (Table 1).
We showed that Linear Discriminant Analysis, 
Quadratic Discriminant Analysis, Logistic 
Regression, Support Vector Machine and Neural 
Networks were the ﬁ  ve most robust supervised 
classiﬁ  cation methods in our study. The combina-
tion of the two-sided Wilcoxon’s test and the 
Logistic Regression for the markers pre-selection 
and the Linear Discriminant Analysis seemed to 
be the more effective in term of classiﬁ  cation of 
samples in control and cancer groups. We observed 
that once the most discriminating markers are 
selected, the results of sensitivity, speciﬁ  city and 
accuracy can be radically different from one 
method to another. The choice of these classiﬁ  cation 
methods depends on the data, on the choice made 
for the pre-selection and on the problem that has 
to be solved. Also, it is essential to test several 
classiﬁ  cation methods on the selected biomarkers. 
The question of the bias between the selection 
method and the Discriminant Analysis can arise. 
Accordingly we evaluated the whole method 
(i.e. the preselection stage combined with the 
Discriminant Analysis) in a 5-fold cross-validation 
(Ambroise, 2002). If we consider the preselection 
method with the logistic regression forward, we 
found an accuracy of 0.8763, a sensitivity of 
0.9027, and a speciﬁ  city of 0.7. The combination 
Table 3. Cross-validation for common peaks.
 Training    TP  TN  FP  FN  Sensitivity  Speciﬁ  city  Accuracy
 sample             
 size  (%)           
Binary logistic    0.4 80169  10970  3030  7831  0.9110  0.7836  0.8935
regression  0.6 52459  7542  1458  5541  0.9045  0.8380  0.8955
  0.8 26258  4256  744  2742  0.9054  0.8512  0.8975
SVM  0.4 81890  9144  4856  6110  0.9306  0.6531  0.8925
  0.6 54293  6543  2457  3707  0.9361  0.7270  0.9080
  0.8 27333  3769  1231  1667  0.9425  0.7538  0.9148
LDA  0.4 81219  11258  2742  6781  0.9229  0.8041  0.9066
  0.6 54271  7380  1620  3729  0.9357  0.8200  0.9202
  0.8 27320  4021  979  1680  0.9421  0.8042  0.9218
QDA  0.4 78654  8663  5337  9346  0.8938  0.6188  0.8560
  0.6 50593  6991  2009  7407  0.8723  0.7768  0.8595
  0.8 25080  4048  952  3920  0.8648  0.8096  0.8567
Neura  0.4 86002  9173  5197  1998  0.9773  0.6383  0.9297
Networks  0.6 56730  6180  2820  1270  0.9781  0.6867  0.9390
  0.8 28511  3341  1659  489  0.9831  0.6682  0.9368
Classiﬁ  cation   0.4 80836  3530  10470  7164  0.9186  0.2521  0.8271
Trees  0.6 53349  2623  6377  4651  0.9198  0.2914  0.8354
  0.8 26795  1439  3561  2205  0.9240  0.2878  0.8304
Boosting  0.4 79569  2546  9603  1164  0.9856  0.2096  0.8841
Trees  0.6 52099  1478  8392  852  0.9839  0.1497  0.8529
  0.8 25924  708  9136  440  0.9833  0.0719  0.7355305
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of this selection method and this classiﬁ  cation 
method is robust. But these performances could be 
better if the difference between sizes of the two 
groups had not been so important. The relatively 
low speciﬁ  city obtained with our data could be 
explained by this strong imbalance in the size of 
both sample groups, or by the choice of a control 
group with high-risk of developping cancer. This 
last condition could explain the very low speciﬁ  city 
observed with the Classiﬁ  cation Trees and the 
Boosting Trees classiﬁ  cation methods, which uses 
thresholds. In conclusion, this biomarkers selection 
method should be employed on other studies, to 
validate its robustness. It also would be interesting 
to ensure a medium term follow-up of this control 
group population to allow the reappraisal of benign 
condition and rule out the possibility of infra 
clinical and radiological cancer development in 
this group of patient. In this case, it could allow a 
correct reallocation of the patient in the correct 
group and a more efﬁ  cient re-evaluation of the 
different classiﬁ  cation methods. Finally, the poten-
tial markers selected should be clearly identiﬁ  ed 
and annotated using extra puriﬁ  cation such as 
standard chromatography and/or electrophoresis 
and analysis by peptide mass ﬁ  ngerprint using 
more resolutive MS techniques or peptide 
sequencing via tandem MS analysis. This identi-
fication presents several interesting features, 
particularly during the discovery phase, by adding 
a supplementary validation phase using inde-
pendent immunological methods, such as ELISA, 
and by increasing the predictive value of the 
molecular signature.
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